Senti Biosciences Holdings, Inc

SNTINASDAQ · Biological Products, (No Diagnostic Substances)

Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

31.1M

on 2026-06-30, from 4.57M on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-10 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2025-03-21. 2 prospectus supplements filed under it since. S-3 ↗

$17.5M

Senti Biosciences, agreement of 2026-05-01. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-14 is not read yet.

Cash

0.7 quarters

$6.5M on 2026-06-30 ÷ $9.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-05-01	Private placement	not read	$0.6261	not stated	8-K ↗

Also on file: up to $40.0M convertible notes agreed 2026-04-27 8-K ↗ · $10.0M convertible notes, 2026-05-20 8-K ↗ · $10.0M convertible notes, 2026-07-14 8-K ↗ · $4.0M convertible notes, 2026-08-14 8-K ↗ · $2.0M convertible notes, 2026-09-03 8-K ↗